Log in

300255 Hebei Changshan Biochemical Pharmaceutical Co., Ltd. SZSE · China

Hebei Changshan Biochemical Pharmaceutical Co. (300255) news

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 300255, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Hebei Changshan Biochemical Pharmaceutical Co. news

We have not published a story on Hebei Changshan Biochemical Pharmaceutical Co. yet. When there is news, it will appear here.

Questions about Hebei Changshan Biochemical Pharmaceutical Co.

What is the ticker symbol of Hebei Changshan Biochemical Pharmaceutical Co.?

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. trades under the ticker 300255 on SZSE.

Where is Hebei Changshan Biochemical Pharmaceutical Co. listed?

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is listed on SZSE.

Which country or territory is Hebei Changshan Biochemical Pharmaceutical Co. listed under?

Our directory records Hebei Changshan Biochemical Pharmaceutical Co., Ltd. under China.

What does Hebei Changshan Biochemical Pharmaceutical Co. do?

Our directory classifies Hebei Changshan Biochemical Pharmaceutical Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Hebei Changshan Biochemical Pharmaceutical Co.?

The ISIN recorded for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is CNE1000016C2.

Does aibio.space cover Hebei Changshan Biochemical Pharmaceutical Co.?

aibio.space lists Hebei Changshan Biochemical Pharmaceutical Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Hebei Changshan Biochemical Pharmaceutical Co.?

Companies in our directory listed in the same country and business area as Hebei Changshan Biochemical Pharmaceutical Co.: EVOPOINT BIOSCIENCES CO LTD, Wuxi Biologics (Cayman), Shenzhen Weiguang Biological Products Co., Shanghai Obio Technology (Group) Corp., Chongqing Zhifei Biological Products Co., Jiangxi Institute of Biological Products.

Investor discussion: Hebei Changshan Biochemical Pharmaceutical Co.

Members talk about Hebei Changshan Biochemical Pharmaceutical Co. (300255). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SZSE:300255 on TradingView.

Listing details

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 300255, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Ticker
300255
Listing
SZSE
Country or territory
China
Business scope
Biotechnology
ISIN
CNE1000016C2
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.